Two new diterpenoic acids isolated from Carpesium divaricatum exhibited growth-inhibitory activity against epithelial–mesenchymal transition-induced cells
{"title":"Two new diterpenoic acids isolated from Carpesium divaricatum exhibited growth-inhibitory activity against epithelial–mesenchymal transition-induced cells","authors":"Hirotaka Matsuo , Hitomi Kawakami , Noriaki Kawano , Hiroyuki Fuchino , Kayo Yoshimatsu","doi":"10.1016/j.tet.2025.134854","DOIUrl":null,"url":null,"abstract":"<div><div>Epithelial–mesenchymal transition (EMT) has recently been reported to be associated with cancer invasion, metastasis, and resistance. Novel cancer treatment strategies should focus on controlling EMT. In a previous study, we established a screening method for growth inhibitors in EMT-induced (EMTed) Madin–Darby canine kidney (MDCK) cells. During screening, a methanolic extract of <em>Carpesium divaricatum</em> showed growth-inhibitory activity against EMTed MDCK cells. After bioguided extract purification, two new diterpenoids, designated divariterpenoic acids A (<strong>1</strong>) and B (<strong>2</strong>), were isolated from the extract, along with two known compounds, 2α,5-epoxy-5,10-dihydroxy-6α-angeloyloxy-9-isobutyloxy-germacran-8,12-olide (<strong>3</strong>) and divaricin B (<strong>4</strong>). The structures of new diterpenoids <strong>1</strong> and <strong>2</strong> were elucidated by 1D and 2D-NMR and HRESI-MS data. Compounds <strong>1</strong>–<strong>4</strong> displayed growth-inhibitory activity on EMTed MDCK cells, with compound <strong>4</strong> showing the strongest activity. Furthermore, the growth-inhibitory activities of compounds <strong>2</strong>–<strong>4</strong> on two EMTed human cancer cell lines, A549 and SAS, were evaluated. Compound <strong>2</strong> inhibited the growth of EMTed SAS cells. Compounds <strong>3</strong> and <strong>4</strong> inhibited the growth of EMTed SAS and A549 cells.</div></div>","PeriodicalId":437,"journal":{"name":"Tetrahedron","volume":"185 ","pages":"Article 134854"},"PeriodicalIF":2.2000,"publicationDate":"2025-07-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tetrahedron","FirstCategoryId":"92","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0040402025004107","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, ORGANIC","Score":null,"Total":0}
引用次数: 0
Abstract
Epithelial–mesenchymal transition (EMT) has recently been reported to be associated with cancer invasion, metastasis, and resistance. Novel cancer treatment strategies should focus on controlling EMT. In a previous study, we established a screening method for growth inhibitors in EMT-induced (EMTed) Madin–Darby canine kidney (MDCK) cells. During screening, a methanolic extract of Carpesium divaricatum showed growth-inhibitory activity against EMTed MDCK cells. After bioguided extract purification, two new diterpenoids, designated divariterpenoic acids A (1) and B (2), were isolated from the extract, along with two known compounds, 2α,5-epoxy-5,10-dihydroxy-6α-angeloyloxy-9-isobutyloxy-germacran-8,12-olide (3) and divaricin B (4). The structures of new diterpenoids 1 and 2 were elucidated by 1D and 2D-NMR and HRESI-MS data. Compounds 1–4 displayed growth-inhibitory activity on EMTed MDCK cells, with compound 4 showing the strongest activity. Furthermore, the growth-inhibitory activities of compounds 2–4 on two EMTed human cancer cell lines, A549 and SAS, were evaluated. Compound 2 inhibited the growth of EMTed SAS cells. Compounds 3 and 4 inhibited the growth of EMTed SAS and A549 cells.
期刊介绍:
Tetrahedron publishes full accounts of research having outstanding significance in the broad field of organic chemistry and its related disciplines, such as organic materials and bio-organic chemistry.
Regular papers in Tetrahedron are expected to represent detailed accounts of an original study having substantially greater scope and details than that found in a communication, as published in Tetrahedron Letters.
Tetrahedron also publishes thematic collections of papers as special issues and ''Reports'', commissioned in-depth reviews providing a comprehensive overview of a research area.